Cited by 42Pituitary Gland Disorders and TreatmentsAdrenal Hormones and DisordersStress Responses and Cortisol

Hair glucocorticoids as a biomarker for endogenous Cushing's syndrome: validation in two independent cohorts

Open access
Savas, Mesut, Wester, Vincent L., de Rijke, Yolanda B., Rubinstein, German, Zopp, Stephanie, Dorst, Kristien, van den Berg, Sjoerd A.A., Beuschlein, Felix +3 more·2019·Neuroendocrinology

Abstract

BACKGROUND/AIMS: The current diagnostic workup of Cushing's syndrome (CS) requires various tests which only capture short-term cortisol exposure, whereas patients with endogenous CS generally have elevated cortisol levels over longer periods of time. Scalp hair assessment has emerged as a convenient test in capturing glucocorticoid concentrations over long periods of time. The aim of this multicenter, multinational, prospective, case-control study was to evaluate the diagnostic efficacy of scalp hair glucocorticoids in screening of endogenous CS. METHODS: We assessed the diagnostic performances of hair cortisol (HairF), hair cortisone (HairE), and the sum of both (sumHairF+E), as measured by a state-of-the-art LC-MS/MS technique, in untreated patients with confirmed endogenous CS (n = 89) as well as in community controls (n = 295) from the population-based Lifelines cohort study. RESULTS: Both glucocorticoids were significantly elevated in CS patients when compared to controls. A high diagnostic efficacy was found for HairF (area under the curve 0.87 [95% CI: 0.83-0.92]), HairE (0.93 [0.89-0.96]), and sumHairF+E (0.92 [0.88-0.96]) (all p < 0.001). The participants were accurately classified at the optimal cutoff threshold in 86% of the cases (81% sensitivity, 88% specificity, and 94% negative predictive value [NPV]) by HairF, in 90% of the cases (87% sensitivity, 90% specificity, and 96% NPV) by HairE, and in 87% of the cases (86% sensitivity, 88% specificity, and 95% NPV) by the sumHairF+E. HairE was shown to be the most accurate in differentiating CS patients from controls. CONCLUSION: Scalp hair glucocorticoids, especially hair cortisone, can be seen as a promising biomarker in screening for CS. Its convenience in collection and workup additionally makes it feasible for first-line screening.

Integrity signals

Registry

Crossref · 10.1159/000498886

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies evaluating hair cortisol and cortisone have reported diagnostic cutoffs ranging from approximately 5-31 pg/mg for hair cortisol and 14-28 pg/mg for hair cortisone, with sensitivities of ∼60-100% and specificities of ∼79-99%, depending on assay methodology, study population, and disease severity.

    “Studies evaluating hair cortisol and cortisone have reported diagnostic cutoffs ranging from approximately 5-31 pg/mg for hair cortisol and 14-28 pg/mg for hair cortisone, with sensitivities of ∼60-100% and specificities of ∼79-99%, depending on assay methodology, study population, and disease severity (Table 3) (119-121).”
  • Hair cortisol and cortisone measurements can distinguish CS from controls.

    “Overall, hair cortisol and cortisone measurements can distinguish CS from controls, but substantial variability in reported cutoffs and diagnostic performance underscores the lack of validated thresholds and the need for further standardization before routine clinical use.”
  • Substantial variability in reported cutoffs and diagnostic performance of hair cortisol and cortisone underscores the lack of validated thresholds.

    “Overall, hair cortisol and cortisone measurements can distinguish CS from controls, but substantial variability in reported cutoffs and diagnostic performance underscores the lack of validated thresholds and the need for further standardization before routine clinical use.”
  • Hair steroid analysis has high diagnostic efficacy in screening of CS.

    “We and others also showed high diagnostic efficacy in screening of CS with hair steroid analysis.”

    From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [48]

  • Hair cortisone has a higher differentiating capacity (sensitivity 87%, specificity 90%) than hair cortisol (sensitivity 81%, specificity 88%).

    “Interestingly, we found that hair cortisone has a higher differentiating capacity (sensitivity 87%, specificity 90%) than hair cortisol (sensitivity 81%, specificity 88%) (48).”

    From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [48]

Cites

Flagged first, then by citations

2 of the 26 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Savas, M., Wester, V. L., de Rijke, Y. B., Rubinstein, G., Zopp, S., Dorst, K., van den Berg, S. A. A., Beuschlein, F., Feelders, R. A., Reincke, M., & van Rossum, E. F. C.
Affiliations
  • Erasmus MC (NL)
  • Ludwig-Maximilians-Universität München (DE)
  • University of Zurich (CH)
Venue
Neuroendocrinology
Publisher
S. Karger AG
Published
2019
Volume
109
Issue
2
Pages
171-178
ISSN
  • 0028-3835 (ISSN-L)
  • 1423-0194
OpenAlex
W2911707353
Cited by
41
References
26
Citations by year
2026: 6 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 8 · 2021: 10 · 2020: 2 · 2019: 4
FWCI
4.87
Type
journal article
Language
en
Open access
Locations
  • Neuroendocrinology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion, cc-by-nc-nd)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc-nd)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • European Commission (HORIZON2020, 694913)
  • Deutsche Forschungsgemeinschaft (CRC/TRR 205, 2012_A103, 2015_A228)
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (91716453)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
Cushing's syndrome, endogenous Cushing's syndrome, hair cortisol, hair cortisone, biomarkers, screening, diagnostic accuracy
MeSH terms
Adult, Aged, Chromatography, Liquid, Cushing Syndrome, Female, Germany, Glucocorticoids, Hair, Humans, Male, Middle Aged, Netherlands, Predictive Value of Tests, Prospective Studies, Sensitivity and Specificity, Cohort Studies, Biomarkers, Case-Control Studies, Tandem Mass Spectrometry

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review